VIA
Vident Investment Advisory’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,844
| Closed | -$831K | – | 643 |
|
|
2023
Q2 | $831K | Sell |
6,844
-7,824
| -53% | -$950K | 0.03% | 529 |
|
|
2023
Q1 | $2.25M | Sell |
14,668
-3,073
| -17% | -$472K | 0.07% | 304 |
|
|
2022
Q4 | $3.19M | Buy |
17,741
+2,275
| +15% | +$409K | 0.12% | 199 |
|
|
2022
Q3 | $1.69M | Buy |
15,466
+13,860
| +863% | +$1.51M | 0.05% | 418 |
|
|
2022
Q2 | $223K | Sell |
1,606
-14,725
| -90% | -$2.04M | 0.01% | 1097 |
|
|
2022
Q1 | $2.81M | Buy |
16,331
+10,817
| +196% | +$1.86M | 0.07% | 299 |
|
|
2021
Q4 | $1.4M | Buy |
5,514
+1,123
| +26% | +$285K | 0.04% | 594 |
|
|
2021
Q3 | $1.69M | Sell |
4,391
-6,609
| -60% | -$2.55M | 0.05% | 505 |
|
|
2021
Q2 | $2.59M | Sell |
11,000
-10,886
| -50% | -$2.56M | 0.08% | 298 |
|
|
2021
Q1 | $2.87M | Sell |
21,886
-4,894
| -18% | -$641K | 0.1% | 213 |
|
|
2020
Q4 | $2.8M | Sell |
26,780
-32,692
| -55% | -$3.42M | 0.11% | 164 |
|
|
2020
Q3 | $4.21M | Sell |
59,472
-38,852
| -40% | -$2.75M | 0.21% | 92 |
|
|
2020
Q2 | $6.31M | Buy |
98,324
+19,220
| +24% | +$1.23M | 0.33% | 67 |
|
|
2020
Q1 | $2.37M | Sell |
79,104
-4,646
| -6% | -$139K | 0.16% | 135 |
|
|
2019
Q4 | $1.64M | Sell |
83,750
-3,660
| -4% | -$71.6K | 0.1% | 310 |
|
|
2019
Q3 | $1.39M | Sell |
87,410
-2,497
| -3% | -$39.8K | 0.12% | 122 |
|
|
2019
Q2 | $1.32M | Buy |
89,907
+7,592
| +9% | +$111K | 0.11% | 135 |
|
|
2019
Q1 | $1.68M | Sell |
82,315
-2,075
| -2% | -$42.2K | 0.09% | 317 |
|
|
2018
Q4 | $1.29M | Buy |
+84,390
| New | +$1.29M | 0.07% | 366 |
|